H. Karppanen, P. Paakkari, A. L. Orma, I. Paakkari: Central hypotensive effects of imidazole acetic acid and rolipram (ZK 62711) in rats. In: Agents Actions. 9, 1979, S. 84–86. PMID 223420.
H. Wachtel: Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors. In: Neuropharmacology. 22, 1983, S. 267–272, PMID 6302550.
C. R. Maxwell, S. J. Kanes, T. Abel, S. J. Siegel: Phosphodiesterase inhibitors: a novel mechanism for receptor-independent antipsychotic medications. In: Neuroscience. 129, 2004, S. 101–107, PMID 15489033.
S. J. Kanes, J. Tokarczyk, S. J. Siegel u. a.: Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity. In: Neuroscience. 144, 2007, S. 239–246, PMID 17081698.
D. E. Griswold, E. F. Webb, J. Breton u. a.: Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. In: Inflammation. 17, 1993, S. 333–344, PMID 7687237.
N. Sommer, P. A. Löschmann, G. H. Northoff u. a.: The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. In: Nat Med. 1, 1995, S. 244–248, PMID 7585041.
C. T. Randt, M. E. Judge, K. A. Bonnet, D. Quartermain: Brain cyclic AMP and memory in mice. In: Pharmacol Biochem Behav 17, 1982, S. 677–680, PMID 6294676.
K. Rutten, J. Prickaerts, G. Schaenzle, H. Rosenbrock, A. Blokland: Sub-chronic rolipram treatment leads to a persistent improvement in long-term object memory in rats. In: Neurobiol Learn Mem. 90, 2008, S. 569–575, PMID 18558503.
F. Block, W. Schmidt, M. Nolden-Koch, M. Schwarz: Rolipram reduces excitotoxic neuronal damage. In: Neuroreport. 12, 2001, S. 1507–1511, PMID 11388438.
E. Valera, F. J. Sánchez-Martín, A. V. Ferrer-Montiel, A. Messeguer, J. M. Merino: NMDA-induced neuroprotection in hippocampal neurons is mediated through the protein kinase A and CREB (cAMP-response element-binding protein) pathway. In: Neurochem. Int. 53, 2008, S. 148–154, PMID 18694792.
E. Zeller, H. J. Stief, B. Pflug, M. Sastre-y-Hernández: Results of a phase II study of the antidepressant effect of rolipram.
In: Pharmacopsychiatry. 17, 1984, S. 188–190. PMID 6393150.
G. F. Hebenstreit, K. Fellerer, K. Fichte u. a.: Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. In: Pharmacopsychiatry. 22, 1989, S. 156–160. PMID 2668980.
W. W. Fleischhacker, H. Hinterhuber, H. Bauer u. a.: A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder. In: Neuropsychobiology. 26, 1992, S. 59–64. PMID 1475038.
